Today: 4 February 2026
Subscribe
Browse Category

NASDAQ:EWTX.O News 14 January 2026

Edgewise Therapeutics stock jumps about 11% on 2026 trial calendar — what’s next for EWTX

Edgewise Therapeutics stock jumps about 11% on 2026 trial calendar — what’s next for EWTX

New York, Jan 14, 2026, 12:55 (EST) — Regular session Shares of Edgewise Therapeutics Inc (EWTX.O) were up 10.6% at $27.59 by 12:55 p.m. EST on Wednesday after the drug developer laid out a 2026 schedule for clinical readouts and trial starts across its muscle-disease and cardiac pipeline. The move matters because Edgewise is still pre-commercial, and its valuation hangs…
14 January 2026
·····

Stock Market Today

  • Altria (MO) Shows Potential Undervaluation Despite Recent Share Gains
    February 4, 2026, 12:48 PM EST. Altria Group's (MO) share price surged 30.7% over the past year, yet a Discounted Cash Flow (DCF) analysis suggests the stock remains undervalued by 42.4%, with an intrinsic value estimate of $111.42 per share. The DCF model considers projected free cash flows, factoring analyst estimates through 2035, indicating the current market price may not fully reflect future earnings potential. Meanwhile, Altria trades at a price-to-earnings (P/E) ratio of 15.5 times, slightly above the tobacco industry average. Investors should weigh these valuation metrics alongside strong recent performance to reassess the stock's true worth amid shifting market conditions. This blend of solid returns and potential undervaluation calls for a closer look at Altria's ongoing investment case.
Go toTop